NCT03329703

Brief Summary

Developed by researchers from the Centers for Disease Control and Prevention (CDC), Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a group telephone program designed to improve depression for people with epilepsy. Project UPLIFT uses evidence-based approaches of cognitive-behavioral therapy (CBT) and mindfulness-based cognitive therapy to help people manage and prevent symptoms of depression. For people with psychogenic non-epileptic seizures, there are few treatment options for depression that address the relationship between mood and seizures. There is evidence that mindfulness-based therapy and cognitive therapy are both effective for people with non-epileptic seizures, both in treating depression and reducing seizure frequency. In this study, Project UPLIFT will be offered to patients with psychogenic non-epileptic seizures. Project UPLIFT is facilitated by a trained clinician to groups of 4-8 patients over the telephone. The group will meet at a regular time, once a week, for 8 consecutive weeks. Participants will be assigned to one of two groups: an immediate-treatment or a waitlist control group which will begin Project UPLIFT 3 months after enrolling in the study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2017

Completed
17 days until next milestone

First Posted

Study publicly available on registry

November 6, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

July 23, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

1.9 years

First QC Date

October 20, 2017

Last Update Submit

September 24, 2021

Conditions

Keywords

PNESUPLIFTDepressionMindfulnessCBTManaging Epilepsy Well (MEW) NetworkPsychogenic SeizuresNon-Epileptic Seizures

Outcome Measures

Primary Outcomes (1)

  • 80% of participants who begin Session 1 of UPLIFT will complete 80% of the sessions.

    To test the feasibility of giving Project UPLIFT to patients with PNES

    6 months

Secondary Outcomes (4)

  • Change in depression (Patient Health Questionnaire-9) before and after intervention.

    6 months

  • Change in seizure frequency as assessed by self-report seizure questionnaire.

    6 months

  • Change in anxiety (Generalized Anxiety Disorder-7) before and after the intervention.

    6 months

  • Change in symptoms of Post-Traumatic Stress Disorder (PTSD Checklist-Civilian Version, PCL-C) before and after the intervention.

    6 months

Study Arms (2)

Immediate-Treatment

EXPERIMENTAL

This group will receive Project UPLIFT immediately after completing surveys.

Behavioral: Project UPLIFT

Waitlist Control

ACTIVE COMPARATOR

This group will receive Project UPLIFT after waiting approximately 3 months to begin the intervention.

Behavioral: Project UPLIFT

Interventions

Project UPLIFTBEHAVIORAL

A group, telephone-based intervention for depression that uses techniques from mindfulness-based therapy and cognitive therapy. The intervention consists of 8 sessions occurring at the same time and day every week.

Immediate-TreatmentWaitlist Control

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • History of psychogenic non-epileptic seizures, confirmed by study investigator.
  • Literate
  • Reliable telephone access

You may not qualify if:

  • Dual diagnosis of PNES with epilepsy.
  • Presence of serious mental illness that will impair ability to participate.
  • Presence of active suicidal ideation at baseline with intention to act.
  • Severe mental disability or estimated intelligent quotient (IQ) less than 70.
  • No reliable telephone access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, 03756, United States

Location

MeSH Terms

Conditions

Psychogenic Nonepileptic SeizuresDepressionSeizures

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehavior

Study Officials

  • Lindsay Schommer, APRN

    Dartmouth-Hitchcock Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Adv Prac Nrs, Neurology

Study Record Dates

First Submitted

October 20, 2017

First Posted

November 6, 2017

Study Start

July 23, 2018

Primary Completion

June 30, 2020

Study Completion

December 31, 2020

Last Updated

September 28, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Individual Participant Data (IPD) are not planned to be shared without outside researchers.

Locations